A Risk-Based Approach to Penicillin Allergy - 23/04/22
Doi : 10.1016/j.iac.2021.12.002
Jason A. Trubiano, BBiomedSci, MBBS, PhD a, b, ⁎ 
a Department of Infectious Diseases, Centre for Antibiotic Allergy and Research, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
b Department of Medicine, Austin Health, University of Melbourne, Heidelberg 3084, Australia
∗Department of Infectious Diseases, Centre for Antibiotic Allergy and Research, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia.Department of Infectious DiseasesCentre for Antibiotic Allergy and ResearchAustin Health145 Studley RoadHeidelbergVictoria3084Australia
Résumé |
Penicillin allergy can be risk stratified in the hospital or outpatient setting to identify low-, moderate-, and high-risk phenotypes. Following ascertainment of risk, dedicated penicillin allergy testing strategies can be deployed successfully for each risk type—direct oral challenge (low risk), skin testing and oral challenge (moderate risk), and specialist review and/or skin testing (high risk).
Le texte complet de cet article est disponible en PDF.Keywords : Antibiotic allergy, Oral provocation, Oral challenge, Antimicrobial stewardship, Drug challenge, Allergy assessment, Allergy risk assessment
Plan
© 2021
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 2
P. 375-389 - mai 2022 Retour au numéro
Article précédent
- Advances in the Pathomechanisms of Delayed Drug Hypersensitivity
- Chuang-Wei Wang, Sherrie Jill Divito, Wen-Hung Chung, Shuen-Iu Hung
- Allergy to Radiocontrast Dye
- Knut Brockow
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?